Percutaneous Revascularization in a Case of Vasospastic Angina Associated with Polymorphic Ventricular Tachycardia

1. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. The American Journal of Medicine. 1959;27:375-388.10.1016/0002-9343(59)90003-8Search in Google Scholar

2. Group JCSJW. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circulation Journal: Official Journal of the Japanese Circulation Society. 2010;74:1745-1762.10.1253/circj.CJ-10-74-0802Search in Google Scholar

3. Ong P, Aziz A, Hansen HS, et al. Structural and Functional Coronary Artery Abnormalities in Patients With Vasospastic Angina Pectoris. Circulation Journal: Official Journal of the Japanese Circulation Society. 2015;79:1431-1438.10.1253/circj.CJ-15-0520Search in Google Scholar

4. Tanabe Y, Itoh E, Suzuki K, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. Journal of the American College of Cardiology. 2002;39:1120-1126.10.1016/S0735-1097(02)01746-1Search in Google Scholar

5. Group JJW. Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina). Circulation Journal. 2010;74:1742-1762.Search in Google Scholar

6. Hiki M, Tokano T, Nakazato Y, Daida H. Recurrent ventricular fibrillation under sufficient medical treatment in patient with coronary artery spasm. Case Reports. 2013; http://casereports.bmj.com/cgi/doi/2012007510.2012001136/bcr-2012002012-2012007583.10.1136/bcr-2012-007583373626023821622Search in Google Scholar

7. Authors/Task Force m, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) * Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal. 2014;35:2541-2619.10.1093/eurheartj/ehu27825173339Search in Google Scholar

8. Task Force M, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34:2949-3003.10.1093/eurheartj/eht29623996286Search in Google Scholar

9. Zeiher AM, Schächlinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 1994;89:2525-2532.10.1161/01.CIR.89.6.25258205660Search in Google Scholar

10. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation. 1987;75:1110-1116.10.1161/01.CIR.75.6.11103568322Search in Google Scholar

11. Tonino PAL, Sels J-WEM, Pijls NHJ. Invasive Physiological Assessment of coronary artery disease, in Eeckhout E, Serruys PW, Wijns W, Vahanian A, Van Sambeek M (eds): Percutaneous interventional cardiovascular medicine: the PCR-EAPCI textbook. 1. Europa éd, Toulouse. 2012;505-528.Search in Google Scholar